Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

517

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Cystic Fibrosis
Interventions
DRUG

Tobramycin Inhalation Powder

Tobramycin Inhalation Powder (TIP) capsules for inhalation.

DRUG

Tobramycin Solution for Inhalation

Tobramycin solution for inhalation (TOBI), supplied as 300 mg/5mL ampoules administered with a nebulizer

Trial Locations (72)

10011

Novartis Investigative Site, New York

10595

Novartis Investigative Site, Valhalla

11040

Novartis Investigative Site, New Hyde Park

11794

Novartis Investigative Site, Stony Brook

12208

Novartis Investigative Site, Albany

13210

Novartis Investigative Site, Syracuse

14222

Novartis Investigative Site, Buffalo

14642

University of Rochester, Rochester

15213

Children's Hospital of Pittsburgh, Pittsburgh

17033

Penn State College of Medicine, Hershey

19102

Drexel University College of Medicine, Philadelphia

22903

University of Virginia Health System, Charlottesville

26506

West Virginia University Health Sciences Center, Morgantown

30322

Emory University CF Center, Atlanta

40202

University of Louisville, Louisville

60596

Klinikum der Johann-Wolfgang-Goethe-Universitaet, Frankfurt

60612

Rush University Center, Chicago

80337

Ludwig-Maximilians-Universitaet, Munich

06102

Novartis Investigative Site, Hartford

02115

Novartis Investigative Site, Boston

03756

Novartis Investigative Site, Lebanon

07039

Novartis Investigative Site, Livingston

07740

Novartis Investigative Site, Long Branch

07967

Novartis Investigative Site, Morristown

08873

Novartis Investigative Site, Somerset

05401

Novartis Investigative Site, Burlington

Unknown

Novartis Investigative Site, South Brisbane

Novartis Investigative Site, Calgary

Novartis Investigative Site, Hamilton

Novartis Investigative Site, Ste-Foy

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Santiago

Novartis Investigative Site, Baranquilla

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Medellín

Novartis Investigative Site, Santiago de Cali

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Paris

Novartis Investigative Site, Rouen

Novartis Investigative Site, Berlin

Novartis Investigative Site, Bochum

Novartis Investigative Site, Bonn

Novartis Investigative Site, Cologne

Novartis Investigative Site, Essen

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Hanover

Novartis Investigative Site, München

Novartis Investigative Site, Hungary

Novartis Investigative Site, Kaposvár

Novartis Investigative Site, Haifa

Novartis Investigative Site, Jerusalem

Novartis Investigative Site, Petah Tikva

Novartis Investigator Site, Genoa

Novartis Investigative Site, Palermo

Novartis Investigative Site, Potenza

Novartis Investigative Site, Roma

Novartis Investigative Site, Monterrey Nuevo Leon

Novartis Investigative Site, Groesbeek

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Barakaldo

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Novartis Investigative Site, Seville

Novartis Investigative Site, Valencia

Novartis Investigative Site, Belfast

Novartis Investigative Site, Birmingham

Novartis Investigative Site, Cambridge

Novartis Investigative Site, Leeds

Novartis Investigative Site, London

Novartis Investigative Site, Sheffield

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY